Mutual Funds Sahi Hai!
To avail the service, you will be redirected to loans.geojitcredits.com
Marksans Pharma announced that its wholly owned subsidiary Relonchem in UK has received Marketing Authorization for the below-mentioned products from UK MHRA:
Marksans Pharma is primarily engaged in the business of research, manufacture, marketing and sale of pharmaceutical formulations.
The company’s consolidated net profit dropped 34.3% to Rs 58.31 crore despite of 4.97% jump in revenue from operations to Rs 619.98 crore in Q1 FY26 over Q1 FY25.